The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumours, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
The global Neurorehabilitation Devices market was valued at US$ 1344.4 million in 2023 and is anticipated to reach US$ 3095.1 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.
North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics
This report aims to provide a comprehensive presentation of the global market for Neurorehabilitation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurorehabilitation Devices.
Report Scope
The Neurorehabilitation Devices market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurorehabilitation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurorehabilitation Devices companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Medtronic
- Abbott Laboratories
- Boston Scientific
- Bioness
- Hocoma AG
- Neuronetics
- Yiruide
- Magstim
- VISHEE
- Ekso Bionics
- Alter G
- MagVenture
- Tyromotion
- Soterix Medical
- Neuroelectrics
- Bionik Laboratories
- Helius Medical
Segment by Type
- Implantable Neurorehabilitation System
- Neurorobotic System
- Brain Computer Interface
- Non-invasive Stimulators
- Other
Segment by Application
- Hospitals
- Clinics
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurorehabilitation Devices companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurorehabilitation Devices Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Implantable Neurorehabilitation System
1.2.3 Neurorobotic System
1.2.4 Brain Computer Interface
1.2.5 Non-invasive Stimulators
1.2.6 Other
1.3 Market by Application
1.3.1 Global Neurorehabilitation Devices Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation Devices Market Perspective (2019-2030)
2.2 Neurorehabilitation Devices Growth Trends by Region
2.2.1 Global Neurorehabilitation Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neurorehabilitation Devices Historic Market Size by Region (2019-2024)
2.2.3 Neurorehabilitation Devices Forecasted Market Size by Region (2025-2030)
2.3 Neurorehabilitation Devices Market Dynamics
2.3.1 Neurorehabilitation Devices Industry Trends
2.3.2 Neurorehabilitation Devices Market Drivers
2.3.3 Neurorehabilitation Devices Market Challenges
2.3.4 Neurorehabilitation Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation Devices Players by Revenue
3.1.1 Global Top Neurorehabilitation Devices Players by Revenue (2019-2024)
3.1.2 Global Neurorehabilitation Devices Revenue Market Share by Players (2019-2024)
3.2 Global Neurorehabilitation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurorehabilitation Devices Revenue
3.4 Global Neurorehabilitation Devices Market Concentration Ratio
3.4.1 Global Neurorehabilitation Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Devices Revenue in 2023
3.5 Neurorehabilitation Devices Key Players Head office and Area Served
3.6 Key Players Neurorehabilitation Devices Product Solution and Service
3.7 Date of Enter into Neurorehabilitation Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurorehabilitation Devices Breakdown Data by Type
4.1 Global Neurorehabilitation Devices Historic Market Size by Type (2019-2024)
4.2 Global Neurorehabilitation Devices Forecasted Market Size by Type (2025-2030)
5 Neurorehabilitation Devices Breakdown Data by Application
5.1 Global Neurorehabilitation Devices Historic Market Size by Application (2019-2024)
5.2 Global Neurorehabilitation Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neurorehabilitation Devices Market Size (2019-2030)
6.2 North America Neurorehabilitation Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neurorehabilitation Devices Market Size by Country (2019-2024)
6.4 North America Neurorehabilitation Devices Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurorehabilitation Devices Market Size (2019-2030)
7.2 Europe Neurorehabilitation Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neurorehabilitation Devices Market Size by Country (2019-2024)
7.4 Europe Neurorehabilitation Devices Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Devices Market Size (2019-2030)
8.2 Asia-Pacific Neurorehabilitation Devices Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2019-2024)
8.4 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurorehabilitation Devices Market Size (2019-2030)
9.2 Latin America Neurorehabilitation Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neurorehabilitation Devices Market Size by Country (2019-2024)
9.4 Latin America Neurorehabilitation Devices Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Devices Market Size (2019-2030)
10.2 Middle East & Africa Neurorehabilitation Devices Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2019-2024)
10.4 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neurorehabilitation Devices Introduction
11.1.4 Medtronic Revenue in Neurorehabilitation Devices Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Neurorehabilitation Devices Introduction
11.2.4 Abbott Laboratories Revenue in Neurorehabilitation Devices Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Detail
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Neurorehabilitation Devices Introduction
11.3.4 Boston Scientific Revenue in Neurorehabilitation Devices Business (2019-2024)
11.3.5 Boston Scientific Recent Development
11.4 Bioness
11.4.1 Bioness Company Detail
11.4.2 Bioness Business Overview
11.4.3 Bioness Neurorehabilitation Devices Introduction
11.4.4 Bioness Revenue in Neurorehabilitation Devices Business (2019-2024)
11.4.5 Bioness Recent Development
11.5 Hocoma AG
11.5.1 Hocoma AG Company Detail
11.5.2 Hocoma AG Business Overview
11.5.3 Hocoma AG Neurorehabilitation Devices Introduction
11.5.4 Hocoma AG Revenue in Neurorehabilitation Devices Business (2019-2024)
11.5.5 Hocoma AG Recent Development
11.6 Neuronetics
11.6.1 Neuronetics Company Detail
11.6.2 Neuronetics Business Overview
11.6.3 Neuronetics Neurorehabilitation Devices Introduction
11.6.4 Neuronetics Revenue in Neurorehabilitation Devices Business (2019-2024)
11.6.5 Neuronetics Recent Development
11.7 Yiruide
11.7.1 Yiruide Company Detail
11.7.2 Yiruide Business Overview
11.7.3 Yiruide Neurorehabilitation Devices Introduction
11.7.4 Yiruide Revenue in Neurorehabilitation Devices Business (2019-2024)
11.7.5 Yiruide Recent Development
11.8 Magstim
11.8.1 Magstim Company Detail
11.8.2 Magstim Business Overview
11.8.3 Magstim Neurorehabilitation Devices Introduction
11.8.4 Magstim Revenue in Neurorehabilitation Devices Business (2019-2024)
11.8.5 Magstim Recent Development
11.9 VISHEE
11.9.1 VISHEE Company Detail
11.9.2 VISHEE Business Overview
11.9.3 VISHEE Neurorehabilitation Devices Introduction
11.9.4 VISHEE Revenue in Neurorehabilitation Devices Business (2019-2024)
11.9.5 VISHEE Recent Development
11.10 Ekso Bionics
11.10.1 Ekso Bionics Company Detail
11.10.2 Ekso Bionics Business Overview
11.10.3 Ekso Bionics Neurorehabilitation Devices Introduction
11.10.4 Ekso Bionics Revenue in Neurorehabilitation Devices Business (2019-2024)
11.10.5 Ekso Bionics Recent Development
11.11 Alter G
11.11.1 Alter G Company Detail
11.11.2 Alter G Business Overview
11.11.3 Alter G Neurorehabilitation Devices Introduction
11.11.4 Alter G Revenue in Neurorehabilitation Devices Business (2019-2024)
11.11.5 Alter G Recent Development
11.12 MagVenture
11.12.1 MagVenture Company Detail
11.12.2 MagVenture Business Overview
11.12.3 MagVenture Neurorehabilitation Devices Introduction
11.12.4 MagVenture Revenue in Neurorehabilitation Devices Business (2019-2024)
11.12.5 MagVenture Recent Development
11.13 Tyromotion
11.13.1 Tyromotion Company Detail
11.13.2 Tyromotion Business Overview
11.13.3 Tyromotion Neurorehabilitation Devices Introduction
11.13.4 Tyromotion Revenue in Neurorehabilitation Devices Business (2019-2024)
11.13.5 Tyromotion Recent Development
11.14 Soterix Medical
11.14.1 Soterix Medical Company Detail
11.14.2 Soterix Medical Business Overview
11.14.3 Soterix Medical Neurorehabilitation Devices Introduction
11.14.4 Soterix Medical Revenue in Neurorehabilitation Devices Business (2019-2024)
11.14.5 Soterix Medical Recent Development
11.15 Neuroelectrics
11.15.1 Neuroelectrics Company Detail
11.15.2 Neuroelectrics Business Overview
11.15.3 Neuroelectrics Neurorehabilitation Devices Introduction
11.15.4 Neuroelectrics Revenue in Neurorehabilitation Devices Business (2019-2024)
11.15.5 Neuroelectrics Recent Development
11.16 Bionik Laboratories
11.16.1 Bionik Laboratories Company Detail
11.16.2 Bionik Laboratories Business Overview
11.16.3 Bionik Laboratories Neurorehabilitation Devices Introduction
11.16.4 Bionik Laboratories Revenue in Neurorehabilitation Devices Business (2019-2024)
11.16.5 Bionik Laboratories Recent Development
11.17 Helius Medical
11.17.1 Helius Medical Company Detail
11.17.2 Helius Medical Business Overview
11.17.3 Helius Medical Neurorehabilitation Devices Introduction
11.17.4 Helius Medical Revenue in Neurorehabilitation Devices Business (2019-2024)
11.17.5 Helius Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
